2014
DOI: 10.1021/mp4005035
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Pyridinium Cationic Lipid–DNA Complex Properties by Pyridinium Gemini Surfactants and Its Impact on Lipoplex Transfection Properties

Abstract: The study presents the effects of blending a cationic gemini surfactant into cationic lipid bilayers and its impact towards plasmid DNA compaction and delivery process. Using nanoDSC, dynamic light scattering, zeta potential and electrophoretic mobility measurements, together with transfection (2D- and 3D-) and viability assays, we identified the main physicochemical parameters of the lipid bilayers, liposomes and lipoplexes that are affected by the gemini surfactant addition. We also correlated the cationic b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

4
49
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 47 publications
(53 citation statements)
references
References 56 publications
4
49
0
Order By: Relevance
“…[45,46] The lowering of the CMC in the presence of hexadecyl chains seems less evident than in the presence of dodecyl chains. This hydrophobic effect of the spacerh as been already observed for ammonium geminis urfactants and is confirmed by the pC 20 values (see the Supporting Information), which generally becomes higher when both the alkyl chains linked to nitrogen atoms and the spacer length increase in as eries. [10] This suggests that the spacer elongation can also significantly affect the properties of surfactant-DNA lipoplexes.…”
Section: Introductionsupporting
confidence: 82%
See 2 more Smart Citations
“…[45,46] The lowering of the CMC in the presence of hexadecyl chains seems less evident than in the presence of dodecyl chains. This hydrophobic effect of the spacerh as been already observed for ammonium geminis urfactants and is confirmed by the pC 20 values (see the Supporting Information), which generally becomes higher when both the alkyl chains linked to nitrogen atoms and the spacer length increase in as eries. [10] This suggests that the spacer elongation can also significantly affect the properties of surfactant-DNA lipoplexes.…”
Section: Introductionsupporting
confidence: 82%
“…[2][3][4][5][6][7][8][9][10] Owing to these properties, the interesti ng emini surfactants, particularly cationic ones, has increased recently in the field of pharmaceuticals, both as noncovalent components in carbon-nanotubebased formulations [11] and as nonviral vectors in gene therapy. [12][13][14][15][16][17][18][19][20] Gene therapy (GT) is finding more and more clinical applications for monogenic disorders, cancer, and infectious diseases. [21][22][23] The first step of GT is to compact and encapsulate the therapeutic desoxyribonucleic acid (DNA) into soft nanoparticles and to deliver it into the nucleus by means of as pecific vector.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1-3 A large number of dicationic and polycationic complexing agents that effectively bind and stabilise nucleic acids and thus can be used in gene therapy 4,5 or in transfer of therapeutic drugs based on siRNA or other short nucleic acids have been described. 6,7 The search for new delivery systems is aimed at development of such compounds that would not only be effective in complexation of nucleic acids, especially siRNA (small interfering RNA), but will also show the lowest possible cytotoxicity.…”
mentioning
confidence: 99%
“…The behaviour of strong DNA-cationic surfactant association has been studied extensively and is linked to some remarkable applications, such as DNA extraction and purification [7][8][9] and gene delivery systems [10][11][12][13][14]. A major current research interest in the pharmaceutical and biotechnology fields is the development of safe and efficient vehicles for controlled gene release.…”
Section: Introductionmentioning
confidence: 99%